• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Expression of phosphorylated Akt and hTERT is associated with prognosis of epithelial ovarian carcinoma.磷酸化Akt和hTERT的表达与上皮性卵巢癌的预后相关。
Int J Clin Exp Pathol. 2015 Nov 1;8(11):14971-6. eCollection 2015.
2
CDKN3 is an independent prognostic factor and promotes ovarian carcinoma cell proliferation in ovarian cancer.细胞周期蛋白依赖性激酶3(CDKN3)是一种独立的预后因素,可促进卵巢癌中卵巢癌细胞的增殖。
Oncol Rep. 2014 Apr;31(4):1825-31. doi: 10.3892/or.2014.3045. Epub 2014 Feb 20.
3
Upregulation of Abelson interactor protein 1 predicts tumor progression and poor outcome in epithelial ovarian cancer.阿贝尔森相互作用蛋白1的上调预示上皮性卵巢癌的肿瘤进展和不良预后。
Hum Pathol. 2015 Sep;46(9):1331-40. doi: 10.1016/j.humpath.2015.05.015. Epub 2015 May 30.
4
Overexpression of ASAP1 is associated with poor prognosis in epithelial ovarian cancer.ASAP1的过表达与上皮性卵巢癌的不良预后相关。
Int J Clin Exp Pathol. 2013 Dec 15;7(1):280-7. eCollection 2014.
5
Elevated expression of MAC30 predicts lymph node metastasis and unfavorable prognosis in patients with epithelial ovarian cancer.MAC30 的高表达预示着上皮性卵巢癌患者的淋巴结转移和不良预后。
Med Oncol. 2013 Mar;30(1):324. doi: 10.1007/s12032-012-0324-7. Epub 2012 Dec 18.
6
MicroRNA-222-3p/GNAI2/AKT axis inhibits epithelial ovarian cancer cell growth and associates with good overall survival.微小RNA-222-3p/鸟嘌呤核苷酸结合蛋白α抑制性多肽2/蛋白激酶B轴抑制上皮性卵巢癌细胞生长并与良好的总生存率相关。
Oncotarget. 2016 Dec 6;7(49):80633-80654. doi: 10.18632/oncotarget.13017.
7
RIF1 promotes human epithelial ovarian cancer growth and progression via activating human telomerase reverse transcriptase expression.RIF1 通过激活人端粒酶逆转录酶的表达促进人上皮性卵巢癌的生长和进展。
J Exp Clin Cancer Res. 2018 Aug 3;37(1):182. doi: 10.1186/s13046-018-0854-8.
8
Significance of MNK1 in prognostic prediction and chemotherapy development of epithelial ovarian cancer.MNK1 在卵巢上皮性癌预后预测及化疗开发中的意义。
Clin Transl Oncol. 2017 Sep;19(9):1107-1116. doi: 10.1007/s12094-017-1646-x. Epub 2017 Mar 22.
9
AKT activation and telomerase reverse transcriptase expression are concurrently associated with prognosis of gastric cancer.AKT 激活和端粒酶逆转录酶表达与胃癌的预后均相关。
Pathobiology. 2014;81(1):36-41. doi: 10.1159/000351721. Epub 2013 Aug 21.
10
Low levels of ADAM23 expression in epithelial ovarian cancer are associated with poor survival.上皮性卵巢癌中ADAM23低表达与较差的生存率相关。
Pathol Res Pract. 2018 Aug;214(8):1115-1122. doi: 10.1016/j.prp.2018.06.007. Epub 2018 Jun 12.

引用本文的文献

1
ShRNA-mediated silencing of hTERT promote apoptosis and senescence in human ovarian cancer cells.短发夹RNA介导的人端粒酶逆转录酶沉默促进人卵巢癌细胞凋亡和衰老。
Transl Cancer Res. 2019 Apr;8(2):567-573. doi: 10.21037/tcr.2019.03.17.
2
Research Progress in Prognostic Factors and Biomarkers of Ovarian Cancer.卵巢癌预后因素及生物标志物的研究进展
J Cancer. 2021 May 13;12(13):3976-3996. doi: 10.7150/jca.47695. eCollection 2021.
3
MicroRNA-153 regulated AKT1 expression and suppressed cell proliferation of epithelial ovarian cancer cells.微小RNA-153调节AKT1表达并抑制上皮性卵巢癌细胞的增殖。
Int J Clin Exp Pathol. 2017 Jul 1;10(7):7417-7426. eCollection 2017.
4
Biologic Mechanisms Linked to Prognosis in Ovarian Cancer that May Be Affected by Aging.与卵巢癌预后相关且可能受衰老影响的生物学机制。
J Cancer. 2019 Jun 2;10(12):2604-2618. doi: 10.7150/jca.29611. eCollection 2019.
5
hERG1 is involved in the pathophysiological process and inhibited by berberine in SKOV3 cells.hERG1参与了病理生理过程,并在SKOV3细胞中被黄连素抑制。
Oncol Lett. 2019 Jun;17(6):5653-5661. doi: 10.3892/ol.2019.10263. Epub 2019 Apr 17.
6
Functional evaluation of synthetic flavonoids and chalcones for potential antiviral and anticancer properties.合成黄酮类化合物和查耳酮的潜在抗病毒和抗癌特性的功能评估。
Bioorg Med Chem Lett. 2017 Jun 1;27(11):2350-2356. doi: 10.1016/j.bmcl.2017.04.034. Epub 2017 Apr 13.

本文引用的文献

1
REDD1 and p-AKT over-expression may predict poor prognosis in ovarian cancer.REDD1和磷酸化AKT的过表达可能预示卵巢癌预后不良。
Int J Clin Exp Pathol. 2014 Aug 15;7(9):5940-9. eCollection 2014.
2
Phosphorylation status of Akt and caspase-9 in gastric and colorectal carcinomas.胃癌和结直肠癌中Akt及半胱天冬酶-9的磷酸化状态
Int J Clin Exp Pathol. 2014 May 15;7(6):3312-7. eCollection 2014.
3
AKT activation and telomerase reverse transcriptase expression are concurrently associated with prognosis of gastric cancer.AKT 激活和端粒酶逆转录酶表达与胃癌的预后均相关。
Pathobiology. 2014;81(1):36-41. doi: 10.1159/000351721. Epub 2013 Aug 21.
4
Prognostically relevant gene signatures of high-grade serous ovarian carcinoma.高级别浆液性卵巢癌的预后相关基因特征。
J Clin Invest. 2013 Jan;123(1):517-25. doi: 10.1172/JCI65833. Epub 2012 Dec 21.
5
Immunohistochemistry with apoptotic-antiapoptotic proteins (p53, p21, bax, bcl-2), c-kit, telomerase, and metallothionein as a diagnostic aid in benign, borderline, and malignant serous and mucinous ovarian tumors.免疫组织化学分析凋亡-抗凋亡蛋白(p53、p21、bax、bcl-2)、c-kit、端粒酶和金属硫蛋白在良性、交界性和恶性浆液性和黏液性卵巢肿瘤中的诊断辅助作用。
Diagn Pathol. 2012 Sep 20;7:124. doi: 10.1186/1746-1596-7-124.
6
Clinicopathologic and biological analysis of PIK3CA mutation in ovarian clear cell carcinoma.卵巢透明细胞癌中 PIK3CA 突变的临床病理和生物学分析。
Hum Pathol. 2012 Dec;43(12):2197-206. doi: 10.1016/j.humpath.2012.03.011. Epub 2012 Jun 15.
7
Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm.上皮性卵巢癌的分子发病机制和卵巢外起源——改变模式。
Hum Pathol. 2011 Jul;42(7):918-31. doi: 10.1016/j.humpath.2011.03.003.
8
Status of PI3K inhibition and biomarker development in cancer therapeutics.PI3K 抑制在癌症治疗中的现状和生物标志物的开发。
Ann Oncol. 2010 Apr;21(4):683-691. doi: 10.1093/annonc/mdp347. Epub 2009 Aug 27.
9
The potential role of Akt phosphorylation in human cancers.Akt磷酸化在人类癌症中的潜在作用。
Int J Biol Markers. 2008 Jan-Mar;23(1):1-9. doi: 10.1177/172460080802300101.
10
Prognostic value of PIK3CA and phosphorylated AKT expression in ovarian cancer.PIK3CA和磷酸化AKT表达在卵巢癌中的预后价值。
Virchows Arch. 2007 Apr;450(4):387-95. doi: 10.1007/s00428-006-0358-3. Epub 2007 Feb 15.

磷酸化Akt和hTERT的表达与上皮性卵巢癌的预后相关。

Expression of phosphorylated Akt and hTERT is associated with prognosis of epithelial ovarian carcinoma.

作者信息

Lee Yoo-Kyung, Chung Hyun Hoon, Kim Jae Weon, Song Yong-Sang, Park Noh-Hyun

机构信息

Department of Obstetrics and Gyneocology, Cheil General Hospital, College of Medicine, Dankook University Seoul, Korea.

Department of Obstetrics and Gynecology, Seoul National University Hospital, College of Medicine, Seoul National University Seoul, Korea.

出版信息

Int J Clin Exp Pathol. 2015 Nov 1;8(11):14971-6. eCollection 2015.

PMID:26823830
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4713616/
Abstract

Activation of human telomere reverse transcriptase (hTERT) is associated with the tumorigenic role of Akt. We aimed to evaluate the significance of Akt phosphorylation and hTERT expression on the prognosis of epithelial ovarian cancer (EOC). Between 2005 and 2012, 92 EOC patients treated at the Seoul National University Hospital were included in this study. Paraffin-embedded sections from the tumors of EOC patients were stained with anti-hTERT and anti-phosphorylated Akt (pAkt) antibodies. Correlations of pAkt and hTERT expression with the clinicopathological factors were analyzed using SPSS software, version 17.0 (IBM, Chicago, IL, USA). In 92 EOC tissues, pAkt and hTERT were not associated with any clinicopathological factors. However, the disease-free survival rate of patients exhibiting coexpression of pAkt and hTERT was poor compared with that of the other patients (P = 0.013). Coexpression of pAkt and hTERT is a poor prognostic marker for EOC.

摘要

人端粒逆转录酶(hTERT)的激活与Akt的致瘤作用相关。我们旨在评估Akt磷酸化和hTERT表达对上皮性卵巢癌(EOC)预后的意义。2005年至2012年期间,本研究纳入了92例在首尔国立大学医院接受治疗的EOC患者。用抗hTERT和抗磷酸化Akt(pAkt)抗体对EOC患者肿瘤的石蜡包埋切片进行染色。使用SPSS 17.0软件(美国伊利诺伊州芝加哥市IBM公司)分析pAkt和hTERT表达与临床病理因素的相关性。在92例EOC组织中,pAkt和hTERT与任何临床病理因素均无关联。然而,与其他患者相比,pAkt和hTERT共表达患者的无病生存率较差(P = 0.013)。pAkt和hTERT共表达是EOC预后不良的标志物。